SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Asyst Technologies (ASYT) Good Value/Where is the Bottom? -- Ignore unavailable to you. Want to Upgrade?


To: Ian@SI who wrote (1335)6/17/1999 12:53:00 PM
From: sergio  Read Replies (1) | Respond to of 2313
 
As copied from CMP semibiznews.com

What will be the impact of this?

Jenoptik's motion in Asyst lawsuit is upheld in
California court

A service of Semiconductor Business News, CMP Media Inc.
Story posted 7:30 p.m. EST/4:30 p.m., PST, 6/16/99

JENA, Germany -- Jenoptik Infab today said U.S. District Judge
Jeremy Fogel in the Northern District of California granted the
company's motion that its IridNet Tracking System does not
infringe on two patents held by rival Asyst Technologies Inc.

"We are pleased with the judge's decision because it is likely to
bring an end to this expensive litigation and reasserts Jenoptik
Infab's leading role in the development of technology for factory
automation and integration," said Wolfgang Mayr, president of
Jenoptik Infab. "We have always been confident that the courts
would rule in our favor but we regret the competitive tactics that
Asyst chose to employ."

All but one claim had been decided in Infab's favor last December
(see Dec. 9, 1998, story). The current decision reconfirmed the
December decision of non-infringement and ruled that a remaining
claim was also not infringed, Jenoptik said.

Asyst did not dispute the ruling in the case of the first two patents.
"That is factually true in the terms of the judge's decision," said
Doug McCutcheon, chief financial officer of Asyst, in Fremont,
Calif. "On the other hand, we believe the judge has used some very
faulty logic in arriving at that decision."

He said Asyst would appeal and "we believe we will prevail on
appeal." That could take time at the appellate level, he said. "In the
meantime, we're no worse off than we were yesterday. We're still
the market leader," McCutcheon said.